MYCOBACTERIUM COMPRISING EXPRESSION VECTOR WITH TWO AUXOTROPHIC SELECTION MARKERS AND ITS USE AS VACCINE - diagram, schematic, and image 13
PDF) A pestivirus DNA vaccine based on a non-antibiotic resistance Escherichia coli essential gene marker | L. El-Attar - Academia.edu
Vaccines | Free Full-Text | Leishmaniac Quest for Developing a Novel Vaccine Platform. Is a Roadmap for Its Advances Provided by the Mad Dash to Produce Vaccines for COVID-19?
Adenovirus (Ad) as Vaccine-vectors - Creative Biolabs
JCI - mRNA vaccine–induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer
Biomaterials at the interface of nano- and micro-scale vector–cellular interactions in genetic vaccine design - Journal of Materials Chemistry B (RSC Publishing) DOI:10.1039/C4TB01058B
Ensuring safety of DNA vaccines | Microbial Cell Factories | Full Text
Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens - ScienceDirect
RNA selectable marker DNA vaccine plasmids. Purple arrow in bacterial... | Download Scientific Diagram
A rapid and robust selection procedure for generating drug-selectable marker-free recombinant malaria parasites | Scientific Reports
Vaccine vial monitor (VVM)
A mass spectrometry guided approach for the identification of novel vaccine candidates in gram-negative pathogens | Scientific Reports
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes | Science
A NOVEL CRE RECOMBINASE-MEDIATED IN VIVO MINICIRCLE DNA (CRIM) VACCINE PROVIDES PARTIAL PROTECTION AGAINST NEWCASTLE DISEASE VIR
MYCOBACTERIUM COMPRISING EXPRESSION VECTOR WITH TWO AUXOTROPHIC SELECTION MARKERS AND ITS USE AS VACCINE - diagram, schematic, and image 12
What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2 - The Lancet Infectious Diseases
Frontiers | B-Cell Immunophenotyping to Predict Vaccination Outcome in the Immunocompromised - A Systematic Review
Glycosite-deleted mRNA of SARS-CoV-2 spike protein as a broad-spectrum vaccine | PNAS
Efficient Bacterial Genome Engineering throughout the Central Dogma Using the Dual-Selection Marker tetAOPT | ACS Synthetic Biology
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers | NEJM
Sucrose selection with RNA-OUT selection marker encoding Nature... | Download Scientific Diagram
Vector Design for Improved DNA Vaccine Efficacy, Safety and Production
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development | ACS Central Science
